deCODE close to broke

Icelandic biotech deCODE Genetics may become another casualty of tough economic times. The company linkurl:announced today;http://tinyurl.com/rcf3pb (August 11) that it has only $3.8 million dollars left in its coffers -- enough to fund operations "into the latter half of the third quarter," which in Iceland runs through September. In a conference call this morning, the company said it was restructuring its business, dropping its medicinal chemistry and structural biology operations, and inste

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Icelandic biotech deCODE Genetics may become another casualty of tough economic times. The company linkurl:announced today;http://tinyurl.com/rcf3pb (August 11) that it has only $3.8 million dollars left in its coffers -- enough to fund operations "into the latter half of the third quarter," which in Iceland runs through September. In a conference call this morning, the company said it was restructuring its business, dropping its medicinal chemistry and structural biology operations, and instead focusing on providing commercial and consumer genetics services. "We are making good progress in recasting deCODE as a leading DNA-based diagnostics company," Kari Stefansson, the company's CEO, said on the call. Going forward, said Stefansson, the three main elements of its business will be the company's consumer genome-based diagnostics business decodeME, as well as scientific services (providing genotyping, sequencing, and data management) and out-licensing for genetic markers. A $10 million deal struck in April, for example, granted genomics company Celera a license to use deCODE-discovered markers for cardiovascular and metabolic disease risk. More such deals, or an alternative infusion of funds, will be needed to keep the company in business, however. The company's stock hit bottom in October last year, though since mid-April it has been steadily increasing from approximately 20 cents a share to 65 cents a share. (Today's stock price as of noon EST is at 61 cents a share.) The company's fall would be "a substantial blow to the field of complex trait genetics," linkurl:the blog Genetic Future;http://scienceblogs.com/geneticfuture/2009/08/decode_genetics_on_the_brink_o.php pointed out, noting that deCODE has "generated an insanely large number of Nature Genetics publications."
**__Related stories:__***linkurl:One biotech gasps for breath;http://www.the-scientist.com/blog/display/55882/
[10th August 2009]*linkurl:DeCODE falls from NASDAQ grace;http://www.the-scientist.com/blog/display/55200/
[18th November 2008 ]*linkurl:Trouble for deCODE;http://www.the-scientist.com/blog/display/55089/
[14th October 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital
Concept illustration of acoustic waves and ripples.

Comparing Analytical Solutions for High-Throughput Drug Discovery

sciex

Products

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome

Magid Haddouchi, PhD, CCO

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer